0 Avaliações

ID

14140

Descrição

Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01509755

Link

https://clinicaltrials.gov/show/NCT01509755

Palavras-chave

  1. 31/03/2016 31/03/2016 -
Transferido a

31 de março de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Eligibility Diabetes NCT01509755

    Eligibility Diabetes NCT01509755

    1. StudyEvent: Eligibility
      1. Eligibility Diabetes NCT01509755
    Inclusion Criteria
    Descrição

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    subjects with type 2 diabetes
    Descrição

    Type 2 Diabetes

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0011860
    duration of diabetes at least 3 months
    Descrição

    Duration of Diabtes

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0872146
    UMLS CUI [1,2]
    C0011860
    both diet treated and patients in therapy with oha (oral hypoglycemic agents)
    Descrição

    Diabetic diet and oral hypoglycemic agents

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0011878
    UMLS CUI [2]
    C0359086
    body mass index maximum 40 kg/m^2
    Descrição

    Body mass index

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1305855
    hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
    Descrição

    Hba1c

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0019018
    Exclusion Criteria
    Descrição

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    liver or renal disease
    Descrição

    Liver or renal disease

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0023895
    UMLS CUI [2]
    C0022658
    cardiac problems
    Descrição

    Cardiac problems

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0262402
    uncontrolled treated/untreated hypertension
    Descrição

    Hypertension

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0020538
    proliferative retinopathy
    Descrição

    Proliferative retinopathy

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0339467
    recurrent severe hypoglycaemia as judged by the investigator
    Descrição

    Recurrent severe hypoglycaemia

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0342316
    known or suspected allergy to trial product or related products
    Descrição

    Allergy to trial product

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C3854006
    use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
    Descrição

    Pharmacotherapy interferes with blood glucose level

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0013216
    UMLS CUI [1,2]
    C0521102
    UMLS CUI [1,3]
    C0392201

    Similar models

    Eligibility Diabetes NCT01509755

    1. StudyEvent: Eligibility
      1. Eligibility Diabetes NCT01509755
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Type 2 Diabetes
    Item
    subjects with type 2 diabetes
    boolean
    C0011860 (UMLS CUI [1])
    Duration of Diabtes
    Item
    duration of diabetes at least 3 months
    boolean
    C0872146 (UMLS CUI [1,1])
    C0011860 (UMLS CUI [1,2])
    Diabetic diet and oral hypoglycemic agents
    Item
    both diet treated and patients in therapy with oha (oral hypoglycemic agents)
    boolean
    C0011878 (UMLS CUI [1])
    C0359086 (UMLS CUI [2])
    Body mass index
    Item
    body mass index maximum 40 kg/m^2
    boolean
    C1305855 (UMLS CUI [1])
    Hba1c
    Item
    hba1c based on analysis from central laboratory: between 7.5-10.0%, both inclusive, for diet treated, or maximum 9.0% for oha treated
    boolean
    C0019018 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Liver or renal disease
    Item
    liver or renal disease
    boolean
    C0023895 (UMLS CUI [1])
    C0022658 (UMLS CUI [2])
    Cardiac problems
    Item
    cardiac problems
    boolean
    C0262402 (UMLS CUI [1])
    Hypertension
    Item
    uncontrolled treated/untreated hypertension
    boolean
    C0020538 (UMLS CUI [1])
    Proliferative retinopathy
    Item
    proliferative retinopathy
    boolean
    C0339467 (UMLS CUI [1])
    Recurrent severe hypoglycaemia
    Item
    recurrent severe hypoglycaemia as judged by the investigator
    boolean
    C0342316 (UMLS CUI [1])
    Allergy to trial product
    Item
    known or suspected allergy to trial product or related products
    boolean
    C0020517 (UMLS CUI [1,1])
    C3854006 (UMLS CUI [1,2])
    Pharmacotherapy interferes with blood glucose level
    Item
    use of any drug (except for ohas) which in the investigator's opinion could interfere with the blood glucose level
    boolean
    C0013216 (UMLS CUI [1,1])
    C0521102 (UMLS CUI [1,2])
    C0392201 (UMLS CUI [1,3])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial